7-(Trifluoromethyl)indoline-2,3-dione: A Potent Inhibitor for Lung Cancer, Diabetes, and Alzheimer's Research

Discover the potent inhibitory capabilities of 7-(Trifluoromethyl)indoline-2,3-dione, a key indole derivative with significant implications for research into lung cancer, diabetes, and Alzheimer's disease. Explore its applications as a pharmaceutical intermediate.

Get a Quote & Sample

Key Advantages

Targeted Therapeutic Research

Leverage the precise inhibitory action of 7-(trifluoromethyl)indoline-2,3-dione against COX-1, COX-2, and β-catenin for focused drug discovery in areas like cancer, diabetes, and Alzheimer's disease research.

Chemical Synthesis Versatility

Utilize this indole derivative as a versatile pharmaceutical intermediate, enabling diverse synthetic pathways for novel therapeutic agents.

High Purity & Quality Assurance

Source a high-purity 7-(trifluoromethyl)indoline-2,3-dione (97% minimum purity) from a reputable supplier in China, ensuring reliable results in your critical research applications.

Key Applications

Oncology Research

Investigate the compound's role in cancer treatment research, particularly for lung cancer, by understanding its COX-1 and COX-2 inhibitory mechanisms.

Diabetes Management Studies

Explore the potential of this chemical inhibitor in diabetes management, focusing on its influence on pathways related to insulin resistance.

Neuroscience Research

Examine the effects of 7-(trifluoromethyl)indoline-2,3-dione in Alzheimer's disease research, particularly its impact on β-catenin pathways.

Pharmaceutical Intermediate Sourcing

Secure a reliable supply of this crucial pharmaceutical intermediate from China for your drug development pipeline.